Glaxosmithkline Investment Services Limited

Company Name	Glaxosmithkline Investment Services Limited
Company Status	Dissolved
Company Number	06968741
Category	Private Limited Company
Incorporation Date	21 July 2009(14 years, 9 months ago)
Dissolution Date	18 April 2022 (2 years ago)

Business Activity

Section N	Administrative and support service activities
SIC 7487	Other business activities
SIC 82990	Other business support service activities n.e.c.

Directors

Director Name	Ms Sarah Ghinn
Date of Birth	August 1963 (Born 60 years ago)
Nationality	British
Status	Closed
Appointed	07 August 2020(11 years after company formation)
Appointment Duration	1 year, 8 months (closed 18 April 2022)
Role	Company Director
Country of Residence	England
Correspondence Address	55 Baker Street London W1U 7EU

Director Name	Mr John Michael Sadler
Date of Birth	March 1956 (Born 68 years ago)
Nationality	British
Status	Closed
Appointed	07 August 2020(11 years after company formation)
Appointment Duration	1 year, 8 months (closed 18 April 2022)
Role	Company Director
Country of Residence	England
Correspondence Address	55 Baker Street London W1U 7EU

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Closed
Appointed	21 July 2009(same day as company formation)
Correspondence Address	Shewalton Road Irvine Ayrshire KA11 5AP Scotland

Director Name	Mr Paul Frederick Blackburn
Date of Birth	October 1954 (Born 69 years ago)
Nationality	British
Status	Resigned
Appointed	21 July 2009(same day as company formation)
Role	Svp, Financial Control
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	05 February 2016(6 years, 6 months after company formation)
Appointment Duration	4 years, 6 months (resigned 07 August 2020)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Resigned
Appointed	21 July 2009(same day as company formation)
Correspondence Address	Shewalton Road Irvine Ayrshire KA11 5AP Scotland

Director Name	Glaxo Group Limited (Corporation)
Status	Resigned
Appointed	21 July 2009(same day as company formation)
Correspondence Address	98 Great West Road Brentford Middlesex TW8 9GS

Contact

Website	gsk.com
Telephone	020 80475000
Telephone region	London

Location

Registered Address	Bdo Llp 55 Baker Street London W1U 7EU
Region	London
Constituency	Cities of London and Westminster
County	Greater London
Ward	Marylebone High Street
Built Up Area	Greater London
Address Matches	9 other UK companies use this postal address

Shareholders

500m at $1	Setfirst LTD 100.00% Ordinary

Financials

Year	2014
Net Worth	£464,405,866
Current Liabilities	£27,159,203

Accounts

Latest Accounts	31 December 2019 (4 years, 4 months ago)
Accounts Category	Total Exemption Full
Accounts Year End	31 December

Filing History

14 August 2017	Full accounts made up to 31 December 2016 (15 pages)
13 June 2017	Confirmation statement made on 6 June 2017 with updates (5 pages)
17 September 2016	Full accounts made up to 31 December 2015 (18 pages)
6 June 2016	Annual return made up to 6 June 2016 with a full list of shareholders Statement of capital on 2016-06-06 USD 500,000,001 (4 pages)
1 March 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
9 February 2016	Appointment of Mr Adam Walker as a director on 5 February 2016 (2 pages)
11 August 2015	Annual return made up to 21 July 2015 with a full list of shareholders Statement of capital on 2015-08-11 USD 500,000,001 (5 pages)
9 June 2015	Full accounts made up to 31 December 2014 (12 pages)
13 August 2014	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 1 October 2009 (1 page)
13 August 2014	Director's details changed for Glaxo Group Limited on 1 October 2009 (1 page)
13 August 2014	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 1 October 2009 (1 page)
13 August 2014	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 1 October 2009 (1 page)
13 August 2014	Annual return made up to 21 July 2014 with a full list of shareholders Statement of capital on 2014-08-13 USD 500,000,001 (5 pages)
13 August 2014	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 1 October 2009 (1 page)
13 August 2014	Director's details changed for Glaxo Group Limited on 1 October 2009 (1 page)
19 May 2014	Full accounts made up to 31 December 2013 (12 pages)
6 September 2013	Full accounts made up to 31 December 2012 (10 pages)
5 August 2013	Annual return made up to 21 July 2013 with a full list of shareholders Statement of capital on 2013-08-05 USD 500,000,001 (5 pages)
29 August 2012	Full accounts made up to 31 December 2011 (10 pages)
20 August 2012	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 21 July 2011 (2 pages)
20 August 2012	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 21 July 2011 (2 pages)
20 August 2012	Annual return made up to 21 July 2012 with a full list of shareholders (5 pages)
20 August 2012	Director's details changed for Glaxo Group Limited on 21 July 2011 (2 pages)
19 August 2011	Annual return made up to 21 July 2011 with a full list of shareholders (15 pages)
26 April 2011	Full accounts made up to 31 December 2010 (10 pages)
24 August 2010	Annual return made up to 21 July 2010 with a full list of shareholders (16 pages)
28 January 2010	Current accounting period extended from 31 July 2010 to 31 December 2010 (3 pages)
21 July 2009	Incorporation (31 pages)

Glaxosmithkline Investment Services Limited

Business Activity

Directors

Contact

Location

Shareholders

Financials

Accounts

Filing History

Contact Companies London